Literature DB >> 25399339

Factors influencing ultrasonographic remission in patients with rheumatoid arthritis.

Halil Harman1, Ibrahim Tekeoğlu, Nedim Kaban, Sibel Harman.   

Abstract

The aim of this study was to define the ultrasonographic factors that indicate clinical remission in patients with RA. We enrolled a cohort of patients with RA in whom the disease had been in remission for at least 6 months. Musculoskeletal ultrasound (US) examination was used to evaluate the status of active synovitis, power Doppler (PD) signalling, and synovitis in the bilateral metacarpophalangeal; proximal interphalangeal; and radiocarpal, ulnocarpal, and intercarpal, compartments of the wrist. A total of 64 RA patients with a mean disease duration of 79.97 months were studied. Of all patients, 36% had ultrasonographic synovitis and 29% an increased PD signal from at least one joint. Delay in diagnosis was highly correlated with synovitis and PD synovitis (r = 0.55, p = 0.000; and r = 0.51, p = 0.001, respectively). A weak negative correlation was evident between synovitis, PD synovitis, tenosynovitis, PD tenosynovitis, and duration of clinical remission (respectively, r = -0.426, p = 0.000; r = -0.333, p = 0.007; r = -0.243, p = 0.050; and r = -0.247, p = 0.049). Upon multivariate logistic regression analysis, the duration of clinical remission and delay in diagnosis were the factors that most influenced ultrasonographic remission (OR 3.46, p = 0.046; OR 3.27, p = 0.016, respectively). Synovial inflammation may persist in RA patients exhibiting clinical remission. We found that US detected subclinical synovitis. The most important factors preventing ultrasonographic remission were a short duration of clinical remission and delay in diagnosis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25399339     DOI: 10.1007/s00296-014-3177-x

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  25 in total

1.  Synovial tissue of the hip at power Doppler US: correlation between vascularity and power Doppler US signal.

Authors:  Markus Walther; Harry Harms; Veit Krenn; Stephan Radke; Stephan Kirschner; Frank Gohlke
Journal:  Radiology       Date:  2002-10       Impact factor: 11.105

2.  The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Phase 2 methodological report.

Authors:  Tuhina Neogi; Daniel Aletaha; Alan J Silman; Raymond L Naden; David T Felson; Rohit Aggarwal; Clifton O Bingham; Neal S Birnbaum; Gerd R Burmester; Vivian P Bykerk; Marc D Cohen; Bernard Combe; Karen H Costenbader; Maxime Dougados; Paul Emery; Gianfranco Ferraccioli; Johanna M W Hazes; Kathryn Hobbs; Tom W J Huizinga; Arthur Kavanaugh; Jonathan Kay; Dinesh Khanna; Tore K Kvien; Timothy Laing; Katherine Liao; Philip Mease; Henri A Ménard; Larry W Moreland; Raj Nair; Theodore Pincus; Sarah Ringold; Josef S Smolen; Ewa Stanislawska-Biernat; Deborah Symmons; Paul P Tak; Katherine S Upchurch; Jirí Vencovský; Frederick Wolfe; Gillian Hawker
Journal:  Arthritis Rheum       Date:  2010-09

3.  Clinical and ultrasonographic remission determines different chances of relapse in early and long standing rheumatoid arthritis.

Authors:  Giusy Peluso; Alessandro Michelutti; Silvia Bosello; Elisa Gremese; Barbara Tolusso; Gianfranco Ferraccioli
Journal:  Ann Rheum Dis       Date:  2010-11-19       Impact factor: 19.103

Review 4.  Power Doppler: it's a good thing.

Authors:  K J Murphy; J M Rubin
Journal:  Semin Ultrasound CT MR       Date:  1997-02       Impact factor: 1.875

5.  Power Doppler ultrasonography for assessment of synovitis in the metacarpophalangeal joints of patients with rheumatoid arthritis: a comparison with dynamic magnetic resonance imaging.

Authors:  M Szkudlarek; M Court-Payen; C Strandberg; M Klarlund; T Klausen; M Ostergaard
Journal:  Arthritis Rheum       Date:  2001-09

6.  Early rheumatoid arthritis: time to aim for remission?

Authors:  P Emery; M Salmon
Journal:  Ann Rheum Dis       Date:  1995-12       Impact factor: 19.103

7.  The discrepancy between clinical and ultrasonographic remission in rheumatoid arthritis is not related to therapy or autoantibody status.

Authors:  Amelia Spinella; Gilda Sandri; Giacomo Carpenito; Lorenza Belletti; Maria Teresa Mascia
Journal:  Rheumatol Int       Date:  2011-12-25       Impact factor: 2.631

8.  Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression.

Authors:  A K Brown; M A Quinn; Z Karim; P G Conaghan; C G Peterfy; E Hensor; R J Wakefield; P J O'Connor; P Emery
Journal:  Arthritis Rheum       Date:  2006-12

9.  Relevance of grade 1 gray-scale ultrasound findings in wrists and small joints to the assessment of subclinical synovitis in rheumatoid arthritis.

Authors:  Matthias Witt; Felix Mueller; Axel Nigg; Christiane Reindl; Jan Leipe; Fabian Proft; Nicola Stein; Ariane Hammitzsch; Stefan Mayer; Claudia Dechant; Hendrik Schulze-Koops; Mathias Grunke
Journal:  Arthritis Rheum       Date:  2013-07

10.  Elucidation of the relationship between synovitis and bone damage: a randomized magnetic resonance imaging study of individual joints in patients with early rheumatoid arthritis.

Authors:  Philip G Conaghan; Philip O'Connor; Dennis McGonagle; Paul Astin; Richard J Wakefield; Wayne W Gibbon; Mark Quinn; Zunaid Karim; Michael J Green; Susanna Proudman; John Isaacs; Paul Emery
Journal:  Arthritis Rheum       Date:  2003-01
View more
  3 in total

1.  Risk factors of flare in rheumatoid arthritis patients with both clinical and ultrasonographic remission: a retrospective study from China.

Authors:  Jingjing Han; Yan Geng; Xuerong Deng; Zhuoli Zhang
Journal:  Clin Rheumatol       Date:  2017-06-22       Impact factor: 2.980

2.  Ultrasound remission in patients with rheumatoid arthritis in clinical remission.

Authors:  Rym Fakhfakh; Nejla Elamri; Khadija Baccouche; Sadok Laataoui; Hela Zeglaoui; Elyes Bouajina
Journal:  Reumatologia       Date:  2022-01-05

3.  Combination of Methotrexate and Leflunomide Is Efficient and Safe for 60 Patients with Rheumatoid Arthritis.

Authors:  Fang Chen; Yingfang Wang; Liuqing Wang; Hongwei Du; Shan He
Journal:  Comput Math Methods Med       Date:  2022-10-03       Impact factor: 2.809

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.